通过合作, SynSmart 和 Amporin 将开发用于退行性疾病的小分子治疗药物. SynSmart and Amporin partner to develop small molecule therapeutics for degenerative diseases.

通过合作, SynSmart 和 Amporin 在治疗退行性疾病方面开发了小分子疗法. SynSmart and Amporin have partnered to develop small molecule therapeutics for degenerative diseases. 美国的SynSmart将合成聚焦膜保护的化合物,而Amporin则计划进行化学和ADME-PK研究. SynSmart will synthesize compounds focusing on membrane protection, while Amporin plans follow-on chemistry and ADME-PK studies. 通过早期研究和战略联盟,合作旨在加速发现疾病修饰治疗方法. The collaboration aims to accelerate the discovery of disease-modifying treatments through early-stage research and strategic alliances.